Clinical Trials Directory

Trials / Unknown

UnknownNCT06035029

Intestinal Flora and Metabonomics of Appendicitis

Research on Intestinal Flora and Metabonomics of Appendicitis in Children

Status
Unknown
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
HongyiQu · Academic / Other
Sex
All
Age
1 Year – 14 Years
Healthy volunteers
Accepted

Summary

The goal of this observational study is to learn about the key bacterial flora and metabolites associated with appendicitis in children. The main questions it aims to answer are: * To screen out the key biomarkers of pediatric appendicitis. * What are the microbial differences in different parts of pediatric appendicitis patients. Participants will detect feces using 16s ribosomal RiboNucleicAcid (16S rRNA) gene sequencing technology and differences of the fecal metabolites between healthy children and appendicitis children were analyzed using untargeted metabolomics based on Liquid chromatography-tandem mass spectrometry(LC-M S/MS) platform.Through the analysis of intestinal bacterial flora and metabolomics association and the differential analysis of intestinal bacterial flora in different parts of the case group, the key bacterial flora and metabolites were excavated.

Detailed description

Participants will detect feces using 16s ribosomal RiboNucleicAcid (16S rRNA) gene sequencing technology and differences of the fecal metabolites between healthy children and appendicitis children were analyzed using untargeted metabolomics based on Liquid chromatography-tandem mass spectrometry(LC-M S/MS) platform. Differences in the intestinal flora of different parts of the case group: the intestinal flora of the case group in feces and rectum were detected by 16s ribosomal RiboNucleicAcid (16S rRNA) gene sequencing technology, and the intestinal flora of different parts were analyzed and compared. Through the analysis of intestinal bacterial flora and metabolomics association and the differential analysis of intestinal bacterial flora in different parts of the case group, the key bacterial flora and metabolites were excavated.

Conditions

Timeline

Start date
2023-04-03
Primary completion
2025-01-01
Completion
2025-07-01
First posted
2023-09-13
Last updated
2023-09-13

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06035029. Inclusion in this directory is not an endorsement.